Population-based biobanks promise to be important resources for genetic research. However, the study of normal genomic variation across populations requires the collection of data and biological samples from individuals on a large scale. While international collaboration has become both a scientific and an ethical imperative, international sharing of data and samples poses many challenges. Significant variation persists among the legal and ethical norms governing population biobanks in different jurisdictions. Many of these norms do not clearly provide for international access. To illustrate these problems, we collected and compared applicable legislative instruments, as well as ethical guidelines issued by national, regional, and international bodies. In addition, harmonization is faced with important limitations and may not be sufficient to ensure effective international sharing. Population biobanks are therefore looking for new ways to promote sharing and improve interoperability. The formation of biobank networks and the development of common governance tools are two approaches that are setting the groundwork for international collaboration in genetic research.

Keywords:
Biobanking, Population biobanking, Law, Ethics, Harmonization
1.
Knoppers BM, Abdul-Rahman (Zawati) MH: Health privacy in genetic research: populations and persons. Politics Life Sci 2009;28:99-101.
2.
Burton P, Hansell A, Fortier I, Manolio T, Khoury M, Little J, Elliot P: Size matters: just how big is BIG? Int J Epidemiol 2009;38:263-273.
3.
European Society of Human Genetics: Data storage and DNA banking for biomedical research: technical, social and ethical issues. Eur J Hum Genet 2003;11(S2):S8-S10.
4.
Human Genome Organisation Ethics Committee: Statement on human genomic databases. Eubios J Asian Int Bioeth 2003;13:99.
5.
Council of Europe: Recommendation Rec (2006)4 of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin. Strasbourg, Council of Europe, 2006.
6.
Cutter AM, Wilson S, Chadwick R: Balancing powers: examining models of biobank governance. J Int Biotechnol Law 2004;1:187-192.
7.
Iceland: Act on Biobanks. No. 110/2000.
8.
Iceland: Regulations on the Keeping and Utilisation of Biological Samples in Biobanks. No. 134/2001.
9.
Iceland: Act on the Protection of Privacy as Regards the Processing of Personal Data. No. 77/2000.
10.
Sweden: Biobanks in Medical Care Act. SFS (2002:297).
11.
Stjernschantz Forsberg J: Biobank research: individual rights and public benefit. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 2012;762.
12.
Norway: Act Relating to Biobanks, No. 12. February 21, 2003.
13.
Norway: Act on Medical and Health Research, No. 44. June 20, 2008.
14.
United Kingdom: Human Tissue Act 2004, c 30.
15.
Cordell S: Biobanking: ethics, governance, and regulation; in Beier K, Schnorrer S, Hoppe N, Lenk C (eds): The Ethical and Legal Regulation of Human Tissue and Biobank Research in Europe. Creative Commons 2011;119-130.
16.
Québec: An act respecting medical laboratories, organ, tissue, gamete and embryo conservation, and the disposal of human bodies, RSQ, c L-02, 2011.
17.
Estonia: Human genes research act, RT I 2000, 104, 685.
18.
Belgium: Loi relative à l'obtention et à l'utilisation de matériel corporel humain destiné à des applications médicales humaines ou à des fins de recherche scientifique, No. 18385, December 19, 2008.
19.
Switzerland: Loi fédérale relative à la recherche sur l'être humain, September 30, 2011.
20.
Beier K, Lenk C: A unified European approach on tissue research and biobanking? A comparison; in Cutter AM, Gordijn B, Marchant GE, Pompidou A (eds): Biobanks and Tissue Research. Springer, 2011, vol 8, pp 143-164.
21.
Caulfield T, Kaye J: Broad consent in biobanking: reflections on seemingly insurmountable dilemmas. Med Law Int 2009;10:85-100.
22.
Gibbons SMC: Are UK genetic databases governed adequately? A comparative legal analysis. Leg Stud 2007;27:312-342.
23.
Knoppers BM, Abdul-Rahman (Zawati) MH, Bédard K: Genomic databases and international collaboration. Kings Coll Law J 2007;18:291-311.
24.
Gertz R: An analysis of the Icelandic Supreme Court judgement on the Health Sector Database Act. SCRIPTed 2004;1:241-258.
25.
Campbell A, Cranley Glass K: The legal status of clinical and ethics policies, codes, and guidelines in medical practice and research. McGill Law J 2001;46:473-489.
26.
Principles Agreed at the First International Strategy Meeting on Human Genome Sequencing. Bermuda, Human Genome Organisation, 1996.
27.
Statement on DNA Sampling: Control and Access. Singapore, Human Genome Organisation Ethics Committee, 1998.
28.
Sharing Data from Large-Scale Biological Research Projects: A System of Tripartite Responsibility. Fort Lauderdale, Human Genome Organisation, 2003.
29.
International Declaration on Human Genetic Data. Paris, United Nations Educational, Scientific and Cultural Organization, 2003.
30.
International Ethical Guidelines for Epidemiological Studies. Geneva, Council for International Organizations of Medical Sciences, 2009.
31.
Guidelines on Human Biobanks and Genetic Research Databases. Paris, Organisation for Economic Co-operation and Development, 2009.
32.
Best Practices for Biospecimen Resources. Bethesda, National Cancer Institute, 2007/2011.
33.
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada: Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. December 2010.
34.
Statement of Principles: Human Genomic Research. Montreal, Network of Applied Genetic Medicine, 2000. www.rmga.qc.ca.
35.
Comité Consultatif National d'Éthique pour les Sciences de la Vie et de la Santé: Avis No. 77. Problèmes éthiques posés pas les collections de matériel biologique et les données d'information associées: ‘biobanques' ‘biothèques'. Paris, CCNE, 2003, France.
36.
Italian Society of Human Genetics: Guidelines for Genetic Biobanks. 2004.
37.
Hansson MG: The need to downregulate: a minimal ethical framework for biobank research. Methods Mol Biol 2011;675:39-59.
38.
Statement on Human Genomic Databases. Singapore, Human Genome Organisation Ethics Committee, 2002.
39.
Riegman PHJ, Morente MM, Betsou F, de Blasio P, Geary P: Biobanking for better healthcare. Mol Oncol 2008:2;213-222.
40.
Joly Y, Allen C, Granados Moreno P: Data sharing, biobanks and informed consent: a research paradox? McGill J Law Health 2013;7:85-120.
41.
The Canadian Tumour Repository Network (CTRNet). www.ctrnet.ca.
42.
International Society for Biological and Environmental Repositories (ISBER). www.isber.org.
43.
International Society for Biological and Environmental Repositories: 2012 Best practices for repositories: collection, storage, retrieval, and distribution of biological materials for research. Biopreserv Biobank 2011;10:79-161.
44.
Public Population Project in Genomics (P3G). www.p3g.org.
45.
Data Schema and Harmonization Platform for Epidemiological Research (DataSHaPER). http://www.datashaper.org/.
46.
Kiehntopf M, Krawczak M: Biobanking and international interoperability: samples. Hum Genet 2011;130:369-376.
47.
Uniform Biological Material Transfer Agreement. Bethesda, National Institutes of Health, 1995. www.bioinfo.com/ubmta.html.
48.
Knoppers BM, Chisholm RL, Kaye J, Cox D, Thorogood A, Burton P, et al: A P3G generic access agreement for population genomic studies. Nat Biotech 2013;31:384-385.
49.
International Policy Interoperability and Data Access Clearinghouse. www.p3g.org/ipac.
50.
Global Alliance for Genomics and Health. http://genomicsandhealth.org/.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.